scPharmaceuticals Inc. financial data

Symbol
SCPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
25 Burlington Mall Road, Suite 203, Burlington, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 900 % +21.4%
Quick Ratio 72.9 %
Debt-to-equity 126 % +98%
Return On Equity -132 % -80.4%
Return On Assets -58.7 % -30.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.1 M shares +0.8%
Common Stock, Shares, Outstanding 36.1 M shares +0.8%
Entity Public Float 274 M USD +263%
Common Stock, Value, Issued 4 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 39 M shares +3.05%
Weighted Average Number of Shares Outstanding, Diluted 39 M shares +3.05%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 4.99 M USD +195%
Research and Development Expense 12.4 M USD -6.64%
General and Administrative Expense 20.6 M USD +111%
Operating Income (Loss) -59.7 M USD -47.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -57.7 M USD -43.1%
Earnings Per Share, Basic -1.48 USD/shares -12.1%
Earnings Per Share, Diluted -1.48 USD/shares -12.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.4 M USD -22.5%
Accounts Receivable, after Allowance for Credit Loss, Current 5.77 M USD +92.1%
Inventory, Net 9.57 M USD +164%
Other Assets, Current 340 K USD +2991%
Assets, Current 76.5 M USD -39.6%
Property, Plant and Equipment, Net 52 K USD +8.33%
Operating Lease, Right-of-Use Asset 1.36 M USD +191%
Assets 78.5 M USD -38.4%
Accounts Payable, Current 2.71 M USD +66.4%
Employee-related Liabilities, Current 2.72 M USD +59.8%
Accrued Liabilities, Current 9.21 M USD +65.5%
Liabilities, Current 12.3 M USD +59.3%
Operating Lease, Liability, Noncurrent 1.23 M USD +24560%
Other Liabilities, Noncurrent 219 K USD +253%
Liabilities 53.9 M USD +4.51%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1 K USD -103%
Retained Earnings (Accumulated Deficit) -295 M USD -24.3%
Stockholders' Equity Attributable to Parent 24.6 M USD -67.6%
Liabilities and Equity 78.5 M USD -38.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.7 M USD -7.32%
Net Cash Provided by (Used in) Financing Activities 14.9 M USD -80.8%
Net Cash Provided by (Used in) Investing Activities 29.3 M USD +319%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 36.1 M shares +0.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.6 M USD +176%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.4 M USD -22.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.47 M USD -1.08%
Deferred Tax Assets, Valuation Allowance 73.2 M USD +23.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 74.3 M USD +24.9%
Operating Lease, Liability 1.42 M USD +234%
Depreciation 24 K USD -29.4%
Payments to Acquire Property, Plant, and Equipment 40 K USD +90.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57.7 M USD -43.2%
Lessee, Operating Lease, Liability, to be Paid 1.92 M USD +333%
Property, Plant and Equipment, Gross 119 K USD -50.8%
Operating Lease, Liability, Current 184 K USD -56.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 349 K USD +34800%
Lessee, Operating Lease, Liability, to be Paid, Year One 341 K USD +3689%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +19.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 502 K USD +2542%
Lessee, Operating Lease, Liability, to be Paid, Year Three 358 K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 1.24 M USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 367 K USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.32 M USD +67.1%
Interest Expense 8.26 M USD +74.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%